Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04808596 · ClinicalTrials.gov registry record
Pulmonary Hypertension Biorepository and Registry
A clinical trial of Pulmonary Hypertension and Pulmonary Arterial Hypertension, sponsored by University of Kansas Medical Center.
- Recruiting
- Registry status
- 300
- Enrollment target
- 1
- Study location
NCT04808596 is a study of Pulmonary Hypertension and Pulmonary Arterial Hypertension that is actively recruiting participants, run by University of Kansas Medical Center. The registered enrollment target is 300 participants, below the 609-participant average among 72 other Pulmonary Hypertension trials with a reported enrollment target (51% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04808596, a study of Pulmonary Hypertension and Pulmonary Arterial Hypertension, is actively recruiting participants, sponsored by University of Kansas Medical Center.
- RECRUITING
- Registry status
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
Establish a pulmonary hypertension registry and biorepository to lead towards a further understanding of the disease.
Conditions Studied
Study Locations (1)
Kansas
- University of Kansas Medical Center - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2020-08-10 |
| Est. Completion | 2027-07-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04808596
The ClinicalTrials.gov registry entry for NCT04808596 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 609-participant average among 72 other Pulmonary Hypertension trials with a reported enrollment target (51% lower). The listed sponsor is University of Kansas Medical Center, which has 408 total studies on file at ClinicalTrials.gov.
The record links to 9 conditions, with Pulmonary Hypertension appearing as the primary indexed condition, and to 0 interventions.
NCT04808596 reports 1 study location spanning 1 distinct geographic area - top geographies include Kansas.
Frequently Asked Questions
What is clinical trial NCT04808596 about?
NCT04808596 is a clinical study titled "Pulmonary Hypertension Biorepository and Registry". Establish a pulmonary hypertension registry and biorepository to lead towards a further understanding of the disease.
What is the current status of trial NCT04808596?
This trial is currently recruiting. The enrollment target is 300 participants. The study started on 2020-08-10. Estimated completion is 2027-07-31.
What conditions does trial NCT04808596 study?
This clinical trial studies the following conditions: Pulmonary Hypertension, Pulmonary Arterial Hypertension, Chronic Thromboembolic Pulmonary Hypertension, Pulmonary Hypertension Due to Lung Diseases and Hypoxia, Pulmonary Hypertension Due to Left Heart Disease.
Who is sponsoring clinical trial NCT04808596?
This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04808596 being conducted?
This trial has 1 study location across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pulmonary Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pulmonary Hypertension Screening in Patients With Interstitial Lung Disease for Earlier Detection
RECRUITING
-
Development of an Algorithm to Detect Pulmonary Hypertension Using an Electronic Stethoscope
RECRUITING
-
Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System
RECRUITING · NA
-
Heart Institute Biobank & Registry for Adult Congenital Heart Disease and Related Disorders
RECRUITING
-
LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF
RECRUITING · Phase 3
-
Hemodynamic Assessment of underLying myocyTe Function in Right Heart Failure
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.